Cardiac troponin I (TNNI3) gene mutations account for 3% of hypertrophic cardiomyopathy and carriers have a heterogeneous phenotype, with increased risk of sudden cardiac death (SCD). The gene discussed is TNNI3; the disease is hypertrophic cardiomyopathy.